MissionIR Articles
-
MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Release, Discuss Q4, FY 2020 Financial Results
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), plans to release its fourth-quarter and full-year financial reports on March 25, 2021, after market close; the numbers will cover the period ending Dec. 31, 2020. The company has…
-
MissionIRNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Launches Probulin Probiotics in China Through World’s Largest Cross-Border Marketplace
HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, through its wholly owned subsidiary Probulin Probiotics LLC, is offering products in China. The products are available on Alibaba Group Holding’s Tmall (“Tmall”) Global, the world’s largest cross-border online marketplace, with a reach…
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Set to Move the World in Memphis
Net Element (NASDAQ: NETE) is in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending stock-for-stock reverse merger with privately-held Mullen Technologies Inc. Mullen today announced its intent to execute a long-term lease on an 820,000-square-foot facility located in Memphis, Tennessee. According to the update, Mullen,…
-
MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Receives European Approval for 25 Minute COVID-19 PCR Test
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT),a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, along with its German diagnostics development partner, 3a-diagnostics GmbH (“3a”), has received European approval of its point-of-care SARS-CoV-2 RT-PCR test system, called Covid-ID Lab. Covid-ID Lab is now registered as a commercial in vitro…
-
MissionIRNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Announces Completion of Uranium Purchases, Additional Funding
Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has secured 800,000 pounds of additional U.S.-warehoused uranium; the shipment is comprised of a delivery in April consisting of 500,000 pounds and a second delivery scheduled for December consisting of 300,000 pounds; this uranium purchase follows a previously announced acquisition of 400,000 pounds.…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Sites for Phase 2B Clinical Trial
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient’s survival and/or quality of life, today announced that it has selected five U.S. clinical sites to enroll patients with ulcerative necrobiosis lipoidica for the company’s Phase 2B trial. In…
-
MissionIRNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Enters Strategic Commercial Agreement
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., has signed a commercial cooperation agreement with SaverOne 2014 Ltd. (TASE: SAVR), a leader in providing an effective solution to combat cell phone distracted driving. According to the update, Eye-Net will integrate…
-
MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Releases Annual, Q4 Financial Results
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) has released its financial numbers for the three- and twelve-month periods ended Dec. 31, 2020. Fourth-quarter financial and operational highlights of the report include a 41% increase in revenues from Q4 2019 ($9 million this quarter compared to $6.4 million in 2019); a gross profit increase…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Advances Psychedelic IND Candidates, Announces Completion of 20th Preclinical Study
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced completion of its 20th preclinical study and is progressing its CYB003 and CYB004 proprietary psychedelic molecules into Investigational New Drug (“IND”)-enabling studies. According to the update, Cybin, through collaboration with its partners and contractors, has completed key research studies both…
-
MissionIRNewsBreaks – Augusta Gold Corp. (CSE: G) (OTCQB: AUGG) (FSE: 11B) Secures Conditional Approval for TSX Listing
Augusta Gold (CSE: G) (OTCQB: AUGG) (FSE: 11B) today announced its receipt of conditional approval to list its common shares on the Toronto Stock Exchange (the “TSX”). Concurrent with the TSX listing, Augusta Gold’s common shares will be de-listed from the Canadian Securities Exchange. Augusta Gold’s trading symbol will remain “G” on the TSX. Final…
-
MissionIRNewsBreaks – Knightscope Inc. Announces Another Crime-Fighting Win
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), today provided an update on another crime-fighting win to add to its long list of successes (see www.Knightscope.com/Crime for others). An article published by the Las Vegas Review-Journal discusses the Knightscope MIN31KS, the human-sized autonomous robot that patrols a Las Vegas…
-
MissionIRNewsBreaks – Brain Scientific Inc. (BRSF) Enters Strategic Collaboration with JelikaLite
Brain Scientific (OTCQB: BRSF), a neurology focused medical device and software company, recently announced a collaboration with JelikaLite, a company developing Cognilum(TM), a non-invasive wearable photobiomodulation device that is being developed to increase the well-being of children living with autism, through a clinical trial. In the trial, “Transcranial Photobiomodulation for Reducing Autism Symptoms in Children,”…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Releases Q1 Revenue, Gross Profit Numbers
Kaival Brands (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has reported its Q1 numbers for the period ending Jan. 31, 2021; the report notes first-quarter revenues of $37 million and gross profit totals of $4.8 million. In addition, the company…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment
AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has announced the completion of enrollment for its phase 2b OPTION 2 clinical trial to investigate MS1819 in cystic fibrosis (“CF”) patients with exocrine pancreatic insufficiency (“EPI”). According to the announcement, the company enrolled 30…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation Schedule for Upcoming March Investor Conferences
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced that its Chief Executive Officer, Shawn Singh, will participate in two investor conferences in March. For the Maxim Group and M-Vest’s Inaugural…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Present at Oppenheimer Health Care Conference
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Oppenheimer 31st Annual Healthcare Conference. Drysdale’s presentation is scheduled to begin at 11:20 a.m. Eastern Time on Thursday, March 18, 2021. Interested parties…
-
MissionIRNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Announces Balance Sheet Update, Physical Uranium Initiative
Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, today announced, in accordance with NYSE American requirements, the filing of its quarterly report on Form 10-Q for the six months ended January 31, 2021 with the U.S. Securities and Exchange Commission (the “SEC”). The Form 10-Q filing, which includes UEC’s…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results
Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec.…
-
MissionIRNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Releases AGMS Results, Names New CEO
Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) held an annual general and special meeting on Monday, March 15, 2021. The company has announced that all matters outlined in the notice of meeting and information circular, which was sent to all shareholders, were approved and passed. Included in those items was the approval and…
-
MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Releases FY 2020 Financial Results, Business Highlights
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has reported business highlights and financial results for the year ended Dec. 31, 2020. Highlights discussed in the report include the company’s reinforced balance sheet with net debt and equity offerings for estimated net proceeds of…
Search Articles
Latest Articles
- Beeline Holdings, Inc. (NASDAQ: BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026
- MissionIRNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Highlighted in Cantor Report for Growth Potential and Sector Strength
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Begin Trading as Solmate (NASDAQ: SLMT) on Oct. 3
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology
- Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’